Literature DB >> 36242711

The lytic phase of Epstein-Barr virus plays an important role in tumorigenesis.

Yue Liang1, Yan Zhang2,3, Bing Luo4.   

Abstract

Epstein-Barr virus (EBV) is a recognized oncogenic virus that is related to the occurrence of lymphoma, nasopharyngeal carcinoma (NPC), and approximately 10% of gastric cancer (GC). EBV is a herpesvirus, and like other herpesviruses, EBV has a biphasic infection mode made up of latent and lytic infections. It has been established that latent infection promotes tumorigenesis in previous research, but in recent years, there has been new evidence that suggests that the lytic infection mode could also promote tumorigenesis. In this review, we mainly discuss the contribution of the EBV lytic phase to tumorigenesis, and graphically illustrate their relationship in detail. In addition, we described the relationship between the lytic cycle of EBV and autophagy. Finally, we also preliminarily explored the influence of the tumorigenesis effect of the EBV lytic phase on the future treatment of EBV-associated tumors.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autophagy; EBV; Lytic; Therapy; Tumorigenesis

Year:  2022        PMID: 36242711     DOI: 10.1007/s11262-022-01940-6

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  84 in total

Review 1.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 2.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

3.  Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

Authors:  J Levitskaya; M Coram; V Levitsky; S Imreh; P M Steigerwald-Mullen; G Klein; M G Kurilla; M G Masucci
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

Review 4.  Encyclopedia of EBV-Encoded Lytic Genes: An Update.

Authors:  Takayuki Murata
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

5.  Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.

Authors:  Jiun-Han Lin; Ju-Yin Lin; Ya-Ching Chou; Mei-Ru Chen; Te-Huei Yeh; Chung-Wu Lin; Sue-Jane Lin; Ching-Hwa Tsai
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

Review 6.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

7.  MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Authors:  Yu-Jin Jung; Hoyun Choi; Hyoji Kim; Suk Kyeong Lee
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

8.  DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.

Authors:  E K Flemington; J P Lytle; C Cayrol; A M Borras; S H Speck
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

Review 9.  Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.

Authors:  J M Middeldorp; D M Pegtel
Journal:  Semin Cancer Biol       Date:  2008-11-01       Impact factor: 15.707

Review 10.  Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.

Authors:  Takayuki Murata; Atsuko Sugimoto; Tomoki Inagaki; Yusuke Yanagi; Takahiro Watanabe; Yoshitaka Sato; Hiroshi Kimura
Journal:  Viruses       Date:  2021-11-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.